medtech

MolecuLight

Imaging device to visualize bacteria in wounds

  • Toronto, Ontario
  • MedTech
  • Invested in 2013

The Story

Moleculight is developing a non-invasive optical technology that acquires images in a manner similar to standard point-and-shoot digital cameras. The device provides real-time bacteriological information which is otherwise unobtainable using industry standard wound assessment techniques, including conventional white light visualization. The first application of this technology will be in the global wound care market where there is an urgent medical need and where MolecuLight can significantly improve outcomes by providing rapid and accurate diagnosis.

MolecuLight’s platform technology is truly innovative and its potential applications represent a compelling growth opportunity in wound care, oncology, home care, food safety, veterinary applications, and cosmetics.

Anil Amlani

CEo, Moleculight

About

  • iGan Partners is a venture capital firm investing in emerging early-stage tech companies with a focus on Digital Health and B2B SaaS.

Copyright © 2018 iGan Partners